BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 16123156)

  • 1. Prolactin specifically activates signal transducer and activator of transcription 5b in neuroendocrine dopaminergic neurons.
    Ma FY; Anderson GM; Gunn TD; Goffin V; Grattan DR; Bunn SJ
    Endocrinology; 2005 Dec; 146(12):5112-9. PubMed ID: 16123156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolactin-regulated tyrosine hydroxylase activity and messenger ribonucleic acid expression in mediobasal hypothalamic cultures: the differential role of specific protein kinases.
    Ma FY; Grattan DR; Goffin V; Bunn SJ
    Endocrinology; 2005 Jan; 146(1):93-102. PubMed ID: 15388649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of prolactin-induced signal transducer and activator of transcription 5b signaling and induction of suppressors of cytokine signaling messenger ribonucleic acid in the hypothalamic arcuate nucleus of the rat during late pregnancy and lactation.
    Anderson GM; Beijer P; Bang AS; Fenwick MA; Bunn SJ; Grattan DR
    Endocrinology; 2006 Oct; 147(10):4996-5005. PubMed ID: 16857756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PRL-induced ERalpha gene expression is mediated by Janus kinase 2 (Jak2) while signal transducer and activator of transcription 5b (Stat5b) phosphorylation involves Jak2 and a second tyrosine kinase.
    Frasor J; Barkai U; Zhong L; Fazleabas AT; Gibori G
    Mol Endocrinol; 2001 Nov; 15(11):1941-52. PubMed ID: 11682625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolactin signalling in the mouse hypothalamus is primarily mediated by signal transducer and activator of transcription factor 5b but not 5a.
    Yip SH; Eguchi R; Grattan DR; Bunn SJ
    J Neuroendocrinol; 2012 Dec; 24(12):1484-91. PubMed ID: 22775396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of signal transducer and activator of transcription (STAT) 5b activation by the temporal pattern of growth hormone stimulation.
    Gebert CA; Park SH; Waxman DJ
    Mol Endocrinol; 1997 Apr; 11(4):400-14. PubMed ID: 9092792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An immunohistochemical approach to monitor the prolactin-induced activation of the JAK2/STAT5 pathway in pancreatic islets of Langerhans.
    Brelje TC; Svensson AM; Stout LE; Bhagroo NV; Sorenson RL
    J Histochem Cytochem; 2002 Mar; 50(3):365-83. PubMed ID: 11850439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of local (intracerebral and intracerebroventricular) administration of tyrosine hydroxylase inhibitor on the neuroendocrine dopaminergic neurons and prolactin release.
    Bodnár I; Hechtl D; Székács D; Oláh M; Nagy GM
    Ideggyogy Sz; 2007 Mar; 60(3-4):177-81. PubMed ID: 17451064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential actions of prolactin on electrical activity and intracellular signal transduction in hypothalamic neurons.
    Brown RS; Piet R; Herbison AE; Grattan DR
    Endocrinology; 2012 May; 153(5):2375-84. PubMed ID: 22416085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine transporters participate in the physiological regulation of prolactin.
    Demaria JE; Nagy GM; Lerant AA; Fekete MI; Levenson CW; Freeman ME
    Endocrinology; 2000 Jan; 141(1):366-74. PubMed ID: 10614659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of prolactin and src/abl kinases on the nuclear translocation of STAT5B and STAT5A.
    Kazansky AV; Kabotyanski EB; Wyszomierski SL; Mancini MA; Rosen JM
    J Biol Chem; 1999 Aug; 274(32):22484-92. PubMed ID: 10428824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin II activates Stat5 through Jak2 kinase in cardiac myocytes.
    McWhinney CD; Dostal D; Baker K
    J Mol Cell Cardiol; 1998 Apr; 30(4):751-61. PubMed ID: 9602424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone- and prolactin-induced proliferation of insulinoma cells, INS-1, depends on activation of STAT5 (signal transducer and activator of transcription 5).
    Friedrichsen BN; Galsgaard ED; Nielsen JH; Møldrup A
    Mol Endocrinol; 2001 Jan; 15(1):136-48. PubMed ID: 11145745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypothalamic targets for prolactin: assessment of c-Fos induction in tyrosine hydroxylase- and proopiomelanocortin-containing neurones in the rat arcuate nucleus following acute central prolactin administration.
    Cave BJ; Wakerley JB; Luckman SM; Tortonese DJ
    Neuroendocrinology; 2001 Dec; 74(6):386-95. PubMed ID: 11752895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restraint stress increases prolactin-mediated phosphorylation of signal transducer and activator of transcription 5 in the hypothalamus and adrenal cortex in the male mouse.
    Kirk SE; Xie TY; Steyn FJ; Grattan DR; Bunn SJ
    J Neuroendocrinol; 2017 Jun; 29(6):. PubMed ID: 28425631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ovarian steroids differentially regulate the expression of PRL-R in neuroendocrine dopaminergic neuron populations: a double label confocal microscopic study.
    Lerant A; Freeman ME
    Brain Res; 1998 Aug; 802(1-2):141-54. PubMed ID: 9748546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dominant negative variants of the SHP-2 tyrosine phosphatase inhibit prolactin activation of Jak2 (janus kinase 2) and induction of Stat5 (signal transducer and activator of transcription 5)-dependent transcription.
    Berchtold S; Volarevic S; Moriggl R; Mercep M; Groner B
    Mol Endocrinol; 1998 Apr; 12(4):556-67. PubMed ID: 9544991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ethanol inhibits prolactin-induced activation of the JAK/STAT pathway in cultured astrocytes.
    DeVito WJ; Stone S
    J Cell Biochem; 1999 Aug; 74(2):278-91. PubMed ID: 10404396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dissociation of Janus kinase 2 and signal transducer and activator of transcription 5 activation after treatment of Nb2 cells with a molecular mimic of phosphorylated prolactin.
    Coss D; Kuo CB; Yang L; Ingleton P; Luben R; Walker AM
    Endocrinology; 1999 Nov; 140(11):5087-94. PubMed ID: 10537136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolactin replacement during development prevents the dopaminergic deficit in hypothalamic arcuate nucleus in prolactin-deficient Ames dwarf mice.
    Romero MI; Phelps CJ
    Endocrinology; 1993 Oct; 133(4):1860-70. PubMed ID: 8104778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.